Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015

Details for Mechanism ID: 13275
Country/Region: Mozambique
Year: 2015
Main Partner: Columbia University
Main Partner Program: Mailman School of Public Health
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $0 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Testing: HIV Testing and Counseling (HVCT) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 15,729
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 68,576
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 45,979
FN_THER Number of clinically malnourished PLHIV who received therapeutic and/or supplementary food during the reporting period 2016 6,178
FN_THER Number of PLHIV who were nutritionally assessed and found to be clinically undernourished 2016 8,232
FPINT_SITE Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2016 117
FPINT_SITE Total number of PEPFAR-supported HIV service delivery points: PMTCT, Care and Treatment 2016 117
HRH_PRE By Graduates: Nurses 2016 30
HRH_PRE Sum of Graduates disaggregates 2016 83
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 64,468
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 175,560
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 550
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 6,280
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 1,375
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 6,280
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 550
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 2,512
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 825
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 3,768
PMTCT_ARV Sum of New and Current disaggregates 2016 1,375
PMTCT_ARV Sum of New and Current disaggregates 2016 6,280
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 4,392
PMTCT_STAT By: Known positives at entry 2016 158
PMTCT_STAT By: Known positives at entry 2016 1,820
PMTCT_STAT By: Number of new positives identified 2016 392
PMTCT_STAT By: Number of new positives identified 2016 4,460
PMTCT_STAT Number of new ANC and L&D clients 2016 29,334
PMTCT_STAT Number of new ANC and L&D clients 2016 53,261
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 33,434
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 55,919
PMTCT_STAT Sum of Positives Status disaggregates 2016 550
PMTCT_STAT Sum of Positives Status disaggregates 2016 6,280
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2016 2,825
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2016 2,542
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 15,729
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 68,576
TX_CURR Age/Sex: <1 Female 2016 145
TX_CURR Age/Sex: <1 Female 2016 644
TX_CURR Age/Sex: <1 Male 2016 145
TX_CURR Age/Sex: <1 Male 2016 644
TX_CURR Age/Sex: 1-4 Female 2016 332
TX_CURR Age/Sex: 1-4 Female 2016 1,467
TX_CURR Age/Sex: 1-4 Male 2016 332
TX_CURR Age/Sex: 1-4 Male 2016 1,467
TX_CURR Age/Sex: 5-14 Female 2016 234
TX_CURR Age/Sex: 5-14 Female 2016 1,035
TX_CURR Age/Sex: 5-14 Male 2016 234
TX_CURR Age/Sex: 5-14 Male 2016 1,035
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 11,010
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 48,003
TX_CURR Sum of age/sex disaggregates 2016 6,292
TX_CURR Sum of Age/Sex disaggregations 2016 1,422
TX_NEW Aggregated Grouping by Age: <1 Male 2016 207
TX_NEW Aggregated Grouping by Age/Sex: <1 Female 2016 207
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2016 12,741
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2016 6,859
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 21,614
TX_NEW Pregnancy status 2016 3,768
TX_NEW Sum of Age/Sex disaggregates 2016 936
TX_NEW Sum of Aggregated Age/Sex disaggregates 2016 19,600
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 12,392
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 17,690